Overview

Obese Patients With Type 2 Diabetes

Status:
Completed

Trial end date:
2004-05-01

Target enrollment:

Participant gender:

Summary

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

Rimonabant